| abstract |
A method of inhibiting breast disorders administering to a human in need of treatment an effective amount of a compound having the formulan n wherein R¹ and R³ are independently hydrogen, -CH₃,n n wherein Ar is optionally substituted phenyl; n R² is selected from the group consisting of pyrrolidine, hexamethyleneamino, and piperidino; or a pharmaceutically acceptable salt of solvate thereof. |